These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 5029425)

  • 1. Effect of pretreatment with spironolactone, phenobarbital or -diethylaminoethyl diphenylpropylacetate (SKF 525-A) on tritium levels in blood, heart and liver of rats at various times after administration of ( 3 H)digitoxin.
    Castle MC; Lage GL
    Biochem Pharmacol; 1972 May; 21(10):1449-55. PubMed ID: 5029425
    [No Abstract]   [Full Text] [Related]  

  • 2. Alteration in the magnitude of induction of tyrosine transaminase by glucocorticoids. II. Effects of phenobarbital, o,p' DDD and diethylaminoethyl diphenylpropylacetate (SKF 525A) on metabolism of triamcinolone acetonide.
    Kupfer D; Partridge R; Jones TM
    Arch Biochem Biophys; 1969 Apr; 131(1):57-66. PubMed ID: 4388684
    [No Abstract]   [Full Text] [Related]  

  • 3. Alteration in the magnitude of induction of tyrosine transaminase by glycocorticoids. The effects of phenobarbital, o,p'DDD and beta-diethylaminoethyl diphenylpropylacetate (SKF 525A).
    Kupfer D
    Arch Biochem Biophys; 1968 Sep; 127(1):200-6. PubMed ID: 4386644
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of spironolactone pretreatment on pharmacokinetics and metabolism of digitoxin in rats.
    VOHRINGER HF; Weller L; Rietbrock N
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287(2):129-39. PubMed ID: 1143356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of phenobarbital and spironolactone pretreatment on digitoxin-induced mortality in male and female rats.
    Talcott RE; Stohs SJ
    Arch Int Pharmacodyn Ther; 1973 Jul; 204(1):86-8. PubMed ID: 4746634
    [No Abstract]   [Full Text] [Related]  

  • 6. H3-digitoxin and its metabolites following spironolactone pretreatment of rats.
    Castle MC; Lage GL
    Res Commun Chem Pathol Pharmacol; 1973 Sep; 6(2):601-12. PubMed ID: 4750104
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased digitoxin cleavage by liver microsomes of spironolactone-pretreated rats.
    Schmoldt A
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Dec; 305(3):261-3. PubMed ID: 740054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of microsomal enzyme inducers on the biliary excretion of cardiac glycosides.
    Klaassen CD
    J Pharmacol Exp Ther; 1974 Nov; 191(2):201-11. PubMed ID: 4418514
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of spironolactone pretreatment on the biliary excretion of digitoxin and its metabolites in male and female rats.
    Kitani K; Sato Y; Kanai S; Nokubo M
    Res Commun Chem Pathol Pharmacol; 1982 Sep; 37(3):355-73. PubMed ID: 7178649
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of 2,4-dichloro-6-phenoxyethyl-amine (DPEA) and -diethylaminoethyl diphenylpropylacetate (SKF-525A) on hepatic microsomal azoreductase activity from phenobarbital or 3-methylcholanthrene induced rats.
    Shargel L; Mazel P
    Biochem Pharmacol; 1972 Jan; 21(1):69-75. PubMed ID: 4400525
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of spironolactone pretreatment on digitoxin metabolism in isolated hepatocytes from male and female rats.
    Ohta M; Sato Y; Kitani K
    Biochem Pharmacol; 1982 Jun; 31(12):2192-4. PubMed ID: 7115439
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of spironolactone and other steroids on the plasma level of digitoxin.
    Solymoss B; Toth S; Varga S; Krajny M
    Recent Adv Stud Cardiac Struct Metab; 1972; 1():605-11. PubMed ID: 4681488
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of the hepatic endoplasmic reticulum in the biliary excretion of foreign compounds by the rat. The effect of phenobarbitone and SKF 525-A (diethylaminoethyl diphenylpropylacetate).
    Levine WG; Millburn P; Smith RL; Williams RT
    Biochem Pharmacol; 1970 Jan; 19(1):235-44. PubMed ID: 5507638
    [No Abstract]   [Full Text] [Related]  

  • 14. Proceedings: Influence of spironolactone pretreatment on pharmakokinetics and metabolism of digitoxin in the rat.
    Vöhringer HF; Stolpmann HJ
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R102. PubMed ID: 4276666
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro digitoxin metabolism. Rate-limiting step and alteration following spironolactone pretreatment.
    Kershaw WC; Campbell P; Lage GL
    Drug Metab Dispos; 1985; 13(6):635-9. PubMed ID: 2867863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excretion of 3H-digitoxin and its metabolites following spironolactone pretreatment in rats.
    Castle MC; Lage GL
    Drug Metab Dispos; 1973; 1(3):590-7. PubMed ID: 4149454
    [No Abstract]   [Full Text] [Related]  

  • 17. The prolongation of reserpine-induced cardiac norepinephrine depletion by metabolic inhibitors.
    Mueller RA; Shideman FE
    Biochem Pharmacol; 1968 Mar; 17(3):451-67. PubMed ID: 5661655
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhanced biliary excretion of digitoxin following sprionolactone as it relates to the prevention of digitoxin toxicity.
    Castle MC; Lage GL
    Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):99-108. PubMed ID: 4686113
    [No Abstract]   [Full Text] [Related]  

  • 19. Selective inhibition of liver-cell proliferation by CFT 1201 and SKF 525 A. Studies on growth processes induced by drugs and by partial hepatectomy.
    Schulte-Hermann R; Schlicht I; Koransky W; Leberl C; Eulenstedt C; Zimek M
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 273(1):109-22. PubMed ID: 4113772
    [No Abstract]   [Full Text] [Related]  

  • 20. In vivo interaction of spironolactone and phenobarbital with cholesterol; effect on cholesterol organ concentration.
    Rekka E; Gouma C; Kourounakis P
    Pharmazie; 1987 Feb; 42(2):107-8. PubMed ID: 3602047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.